top of page
Lyfgenia Treatment Overview - Morning Session
mar 03 de dic
|Lyfgenia Treatment Overview
LYFGENIA is a one-time gene therapy to treat sickle cell disease in patients 12 years of age or older and a history of vaso-occlusive events.
Registration is closed
See other events
Horario y ubicación
03 dic 2024, 11:00 a.m. – 12:00 p.m.
Lyfgenia Treatment Overview
Acerca del evento
Join the Sickle Cell Disease Foundation and Edsel Bester, Patient & Community Education Liaison at BlueBird Bio, for an informational webinar on Lyfgenia.
LYFGENIA is a one-time gene therapy to treat sickle cell disease in patients 12 years of age or older and a history of vaso-occlusive events. LYFGENIA is made specifically for each patient, using the patient’s own blood stem cells (from which red blood cells are produced).
bottom of page